Back to Basics: How COVID-19 revitalized interest in familiar letter vitamins31 Mar 2021
“Preventive healthcare products addressing concerns like immunity are trending higher than symptomatic products; Mattern declares. “In this context, products with vitamins C and D come to mind and benefit from decades of research and hundreds, if not thousands, of scientific publications backing their associated health claims.”
Maheshvari agrees. “Vitamin C has been scientifically proven as vital for immunity.” he notes. “Strong published research also suggests that vitamin E is pivotal as an antioxidant in the immune response. It would appear from later research, too, that vitamin D and K levels are also important factors in how some respond to COVID, and how severely.”
Jia Zhang Lee, executive director, Davos Life Science (Singapore), notes that his company has seen a steady increase in demand for vitamin E tocotrienols in particular. “Research studies have shown that tocotrienols have positive health benefits in the management of hypertension, heart disease, and diabetes,” Lee notes. “These chronic conditions predispose individuals to the more severe form of COVID-19, and therefore there’s been growing interest in tocotrienol supplementation to help promote the prevention of these chronic diseases.”
But plenty of botanicals, antioxidants, probiotics, and other more “exotic” nutritional ingredients have immune associations, too, so why have humble vitamins gotten so much glow?
For one, those “exotic” upstarts, Mattern argues, are “less understood by the wider population.”
Source: Nutritional Outlook (March 2021)